Antibiotics and probiotics in chronic pouchitis: A comparative proteomic approach

Table 2 Summary of identification results of protein spots conserved in pouchitis/pouch remission and normal pouch/probiotic-treated pouch groups

Spot ID	Swiss-Prot Acc. No.	Protein name	COG1	Subcellular location	Theoretical Mr/pI	Experimental Mr/pI	Method of identification2
A	Q15365	Poly(rC)-binding protein 1 (PCBP1)	A	Nucleus	37.53/6.66	35.99/7.17	MALDI-TOF MS
B	Q6IBM5	Rho GDP dissociation inhibitor (GDI) α, isoform CRA_a (ARHGDIA)	T	Cytoplasm	23.21/5.03	25.73/4.99	MALDI-TOF MS
C	Q5R8R5	Glutathione S-transferase P (GSTP1)	O	Cytoplasm	23.36/5.93	24.33/5.80	MALDI-TOF MS
D	P61088	Ubiquitin-conjugating enzyme E2 N (UBE2N)	O	Nucleus	17.14/6.13	19.00/6.10	MALDI-TOF MS
E	P68871	Hemoglobin subunit β (HBB)	C	Extracellular	16.00/6.74	13.10/7.70	MALDI-TOF MS
F	Q1HDT5	Hemoglobin α 1-2 hybrid (HBA1)	C	Extracellular	15.27/9.04	12.50/9.55	MALDI-TOF MS

¹A: RNA processing and modification. For other abbreviations see Table 1;

²For each protein spot, the gel matching identification method was also employed. Spots A, B and D were identified by comparison with published 2D proteome patterns[17,18]; spots C, E and F by comparison with Swiss-2D PAGE.